Predictors of telemedicine use during the COVID-19 pandemic in the United States-an analysis of a national electronic medical record database.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 05 08 2021
accepted: 23 05 2022
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 2 7 2022
Statut: epublish

Résumé

Telemedicine utilization increased significantly in the United States during the COVID-19 pandemic. However, there is concern that disadvantaged groups face barriers to access based on single-center studies. Whether there has been equitable access to telemedicine services across the US and during later parts of the pandemic is unclear. This study retrospectively analyzes outpatient medical encounters for patients 18 years of age and older using Healthjump-a national electronic medical record database-from March 1 to December 31, 2020. A mixed effects multivariable logistic regression model was used to assess the association between telemedicine utilization and patient and area-level factors and the odds of having at least one telemedicine encounter during the study period. Among 1,999,534 unique patients 21.6% had a telemedicine encounter during the study period. In the multivariable model, age [OR = 0.995 (95% CI 0.993, 0.997); p<0.001], non-Hispanic Black race [OR = 0.88 (95% CI 0.84, 0.93); p<0.001], and English as primary language [OR = 0.78 (95% CI 0.74, 0.83); p<0.001] were associated with a lower odds of telemedicine utilization. Female gender [OR = 1.24 (95% CI 1.22, 1.27); p<0.001], Hispanic ethnicity or non-Hispanic other race [OR = 1.40 (95% CI 1.33, 1.46);p<0.001 and 1.29 (95% CI 1.20, 1.38); p<0.001, respectively] were associated with a higher odds of telemedicine utilization. During the COVID-19 pandemic, therefore, utilization of telemedicine differed significantly among patient groups, with older and non-Hispanic Black patients less likely to have telemedicine encounters. These findings are relevant for ongoing efforts regarding the nature of telemedicine as the COVID-19 pandemic ends.

Identifiants

pubmed: 35767530
doi: 10.1371/journal.pone.0269535
pii: PONE-D-21-25426
pmc: PMC9242497
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0269535

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Circulation. 2020 Aug 4;142(5):510-512
pubmed: 32510987
JAMA Intern Med. 2021 Mar 1;181(3):388-391
pubmed: 33196765
JAMA Oncol. 2022 Jan 1;8(1):161-163
pubmed: 34792526
BMJ. 2001 Nov 3;323(7320):1058-60
pubmed: 11691768
BMC Fam Pract. 2016 Mar 31;17:38
pubmed: 27036116
J Am Med Inform Assoc. 2020 Dec 9;27(12):1949-1954
pubmed: 32866249
J Am Med Inform Assoc. 2021 Jan 15;28(1):119-125
pubmed: 32894772
PLoS One. 2021 Mar 24;16(3):e0248702
pubmed: 33760849
J Health Psychol. 2016 Jul;21(7):1283-92
pubmed: 25293967
JAMA Netw Open. 2020 Dec 1;3(12):e2031640
pubmed: 33372974
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
J Am Med Inform Assoc. 2021 Jan 15;28(1):33-41
pubmed: 32866264
J Surg Res. 2019 Nov;243:160-164
pubmed: 31177035
Cancer Pract. 1995 Sep-Oct;3(5):310-6
pubmed: 7663550
JAMA. 2016 May 10;315(18):2015-6
pubmed: 27163991
Cancer Med. 2022 Feb;11(4):1192-1201
pubmed: 34989148
Telemed J E Health. 2022 Jan;28(1):51-59
pubmed: 33769092
Patient Educ Couns. 1989 Apr;13(2):183-99
pubmed: 10303324
J Med Internet Res. 2020 Sep 3;22(9):e21012
pubmed: 32880579
Int J Clin Pract. 2010 Mar;64(4):475-87
pubmed: 20456194
Health Aff (Millwood). 2021 Feb;40(2):349-358
pubmed: 33523745
Ann Intern Med. 2021 Jul;174(7):936-944
pubmed: 33780289
Telemed J E Health. 2015 Aug;21(8):644-51
pubmed: 25839334
Am J Manag Care. 2021 Jan;27(1):21-26
pubmed: 33471458
Int J Telemed Appl. 2012;2012:715194
pubmed: 22997511

Auteurs

Sameed Ahmed M Khatana (SAM)

Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Lin Yang (L)

Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Lauren A Eberly (LA)

Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Center for Health Equity and Social Justice, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Howard M Julien (HM)

Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Center for Health Equity and Social Justice, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Srinath Adusumalli (S)

Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Cardiovascular Center for Health Equity and Social Justice, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Penn Medicine Center for Health Care, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Peter W Groeneveld (PW)

Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Center for Health Equity Research and Promotion, Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH